Verve Therapeutics (VERV)
(Delayed Data from NSDQ)
$6.28 USD
+0.61 (10.76%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $6.28 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
D Value F Growth F Momentum F VGM
Earnings News For VERV
-
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
-
Verve Therapeutics: Q1 Earnings Snapshot
-
Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results
-
Verve Therapeutics: Q4 Earnings Snapshot
-
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2023 Financial Results
-
Verve Therapeutics: Q3 Earnings Snapshot
-
Verve Therapeutics Highlights Recent Company Progress and Reports Third Quarter 2023 Financial Results
-
Verve Therapeutics (VERV) Reports Q2 Loss, Tops Revenue Estimates
-
Verve Therapeutics: Q2 Earnings Snapshot
-
Verve Therapeutics Highlights Recent Company Progress and Reports Second Quarter 2023 Financial Results
-
Verve Therapeutics (VERV) Reports Q1 Loss, Tops Revenue Estimates
-
Verve Therapeutics: Q1 Earnings Snapshot
-
Verve Therapeutics Announces Pipeline Progress and Expansion and Reports First Quarter 2023 Financial Results
-
Verve Therapeutics: Q4 Earnings Snapshot
-
Verve Therapeutics Provides Pipeline Progress and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Verve Therapeutics (VERV) Reports Q3 Loss, Lags Revenue Estimates
-
Verve Therapeutics: Q3 Earnings Snapshot
-
Verve Therapeutics Provides Regulatory Update on VERVE-101 Investigational New Drug Application and Reports Third Quarter 2022 Financial Results
-
Verve Therapeutics: Q2 Earnings Snapshot
-
Verve Therapeutics Provides Corporate Updates and Reports Second Quarter 2022 Financial Results